29/06/2026
Lenacapivir
Lenacapivir is a long-acting antiviral medicine being developed for the prevention of HIV infection. It works by targeting the HIV capsid, a structure that helps the virus survive and multiply. By blocking this process, lenacapivir can prevent HIV from establishing an infection in the body.
A major benefit of lenacapivir is that it can provide protection for a longer period compared to daily HIV prevention pills. This may help improve adherence and offer a more convenient option for people who need HIV prevention.
Lenacapivir is an important advancement in HIV prevention because it provides another choice alongside existing methods such as condoms and oral PrEP. However, it should be used as prescribed by healthcare providers and does not protect against other sexually transmitted infections.